The Transitioning Children to Optimal Regimens of Paediatric Dolutegravir (TORPEDO) Study

The Transitioning children to Optimal Regimens of Paediatric Dolutegravir (TORPEDO) Study was conducted in Benin, Nigeria, and Uganda. The study aims to assess patients’/caregivers’ preference for a paediatric DTG regimen over their previous regimen, when transitioned from another regimen.

Click here to see a slide deck walking through initial results from August 2022, and here to see the updated results as of February 2023.

Access the latest study results here.